QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 限定条件 发表日期：2021    专题：上海药物研究所    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Pharmacodynamic, pharmacokinetic, and phase 1a study of bisthianostat, a novel histone deacetylase inhibitor, for the treatment of relapsed or refractory multiple myeloma 期刊论文 ACTA PHARMACOLOGICA SINICA, 2021, 页码: 9 作者:  Zhou, Yu-bo;  Zhang, Yang-ming;  Huang, Hong-hui;  Shen, Li-jing;  Han, Xiao-feng 收藏  |  浏览/下载：98/0  |  提交时间：2021/11/04 multiple myeloma  HDAC inhibitor  bisthianostat  pharmacodynamics  pharmacokinetics  phase 1a clinical trial  antitumor drug   A novel phosphoramide compound, DCZ0805, shows potent anti-myeloma activity via the NF-κB pathway 期刊论文 Cancer Cell International, 2021, 卷号: 21, 期号: 1 作者:  Gao,Xuejie;  Li,Bo;  Ye,Anqi;  Wang,Houcai;  Xie,Yongsheng 收藏  |  浏览/下载：98/0  |  提交时间：2021/06/11 Multiple myeloma  Anti-tumor activity  NF-κB   A novel phosphoramide compound, DCZ0805, shows potent anti-myeloma activity via the NF-kappa B pathway 期刊论文 CANCER CELL INTERNATIONAL, 2021, 卷号: 21, 期号: 1, 页码: 10 作者:  Gao, Xuejie;  Li, Bo;  Ye, Anqi;  Wang, Houcai;  Xie, Yongsheng 收藏  |  浏览/下载：22/0  |  提交时间：2021/08/17 Multiple myeloma  Anti-tumor activity  NF-kappa B   Discovery of novel ceramide analogs with favorable pharmacokinetic properties and combination with AKT inhibitor against colon cancer 期刊论文 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 215, 页码: 13 作者:  Gao, Feng;  Chen, Xiaoxu;  Lu, Junyan;  Hu, Shulei;  Xu, Hui 收藏  |  浏览/下载：46/0  |  提交时间：2021/05/24 Ceramide analogs  AKT inhibitor  MK2206  Colon cancer  Combination therapy   A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementia 期刊论文 Alzheimer's Research & Therapy, 2021, 卷号: 13, 期号: 1 作者:  Xiao,Shifu;  Chan,Piu;  Wang,Tao;  Hong,Zhen;  Wang,Shuzhen 收藏  |  浏览/下载：156/0  |  提交时间：2021/05/24 Sodium oligomannate  Efficacy  Safety  Alzheimer’s disease  Clinical trial